Back to Search Start Over

Ipsen will acquire rare-disease specialist

Authors :
Rick Mullin
Source :
C&EN Global Enterprise. 97:13-13
Publication Year :
2019
Publisher :
American Chemical Society (ACS), 2019.

Abstract

Ipsen will acquire the Montreal-based rare-disease specialist Clementia Pharmaceuticals in a deal valued at up to $1.3 billion. The deal will net the French drugmaker palovarotene, which it expects...

Subjects

Subjects :
Computer Networks and Communications
Hardware and Architecture
medicine
Medical emergency
Business
medicine.disease
Pediatric Disease
Software
Rare disease

Details

ISSN :
24747408
Volume :
97
Database :
OpenAIRE
Journal :
C&EN Global Enterprise
Accession number :
edsair.doi...........eb40cb248aa1af1359afada155e7d18c
Full Text :
https://doi.org/10.1021/cen-09709-buscon14
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details